Handling and safety of two insulin injection pens (FlexPen® and OptiClik®) in insulin-naive type 2 diabetes patients

被引:0
|
作者
Asakura, Toshinari
Seino, Hiroaki
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A457 / A458
页数:2
相关论文
共 50 条
  • [31] Intensive Insulin Titration with Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study
    Tuncel, Ercan
    Kanat, Mustafa
    Algun, Ekrem
    Gul, Ozen Oz
    Emral, Rifat
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 19 (03) : 83 - 88
  • [32] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Aagren, M.
    Liu, F.
    Bouchard, J.
    Conner, C.
    VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
  • [33] Weight change upon initiation of insulin detemir treatment with or without dietary intervention in insulin-naive patients with Type 2 diabetes
    Hollander, P.
    Piletic, M.
    Silver, H. J.
    Andersen, H.
    Hiort, L. C.
    Niswender, K.
    DIABETIC MEDICINE, 2013, 30 : E6 - E6
  • [34] The Lifestyle Change after Initiating Basal Insulin in Insulin-Naive Patients with Type 2 Diabetes: Results from the ORBIT Study
    Zhu, Dongshan
    Zhang, Heng
    Li, Xian
    Ji, Jiachao
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    Zhang, Puhong
    DIABETES, 2017, 66 : A262 - A262
  • [35] A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes
    Fogelfeld, L.
    Dharmalingam, M.
    Robling, K.
    Jones, C.
    Swanson, D.
    Jacober, S.
    DIABETIC MEDICINE, 2010, 27 (02) : 181 - 188
  • [36] Self-reported impressions of insulin detemir among patients with type 2 diabetes: Insulin-naive vs. prior insulin users
    Kerney, Donna L.
    Paradis, Diana
    Lucrezia, Laurel
    Brunton, Stephen
    DIABETES, 2007, 56 : A537 - A537
  • [37] Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naive type 2 diabetes patients: dropout study
    Yavuz, Dilek Gogas
    Bilen, Habip
    Sancak, Seda
    Garip, Tayfun
    Hekimsoy, Zeliha
    Sahin, Ibrahim
    Yilmaz, Murat
    Aydin, Hasan
    Atmaca, Aysegul
    Sert, Murat
    Karakaya, Pinar
    Arpaci, Dilek
    Oguz, Aytekin
    Guvener, Nilgun
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 851 - 861
  • [38] Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naive Patients with Type 2 Diabetes: The Observational IGLU-SIT Study
    Pfohl, Martin
    Seufert, Jochen
    Borck, Anja
    Bramlage, Peter
    Siegmund, Thorsten
    DIABETES THERAPY, 2021, 12 (03) : 733 - 747
  • [39] USING A FASTING PLASMA GLUCOSE SIMULATOR TO OPTIMIZE BASAL INSULIN (DEGLUDEC) TITRATION IN INSULIN-NAIVE TYPE 2 DIABETES PATIENTS
    El Fathi, A.
    Fabris, C.
    Breton, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A122 - A123
  • [40] Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes"
    Freemantle, Nick
    Jourdan, Sophie
    DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1758 - 1759